27.07.2011 • News

Dow Chemical Sees Positive Q2; Sales Up 18%

Dow reported that its second-quarter net income available to the common shareholders rose to $982 million or $0.84 per share, from $566 million or $0.50 per share in the same quarter last year.

Excluding certain item, net income increased to $989 million or $0.85 per share, from $614 million or $0.54 per share last year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.81 per share for the quarter. Analysts' estimates typically exclude special items.

Net sales for the quarter rose to $16.05 billion from $13.62 billion in the prior year quarter.

Ten analysts had consensus revenue estimate of $14.74 billion for the quarter. Sales increased 18%, driven by price gains of 17% compared with the same period last year.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read